Welcome to our dedicated page for Ensign Group SEC filings (Ticker: ENSG), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Ensign Group, Inc. (Nasdaq: ENSG) files detailed reports with the U.S. Securities and Exchange Commission that describe its post-acute healthcare operations, skilled nursing and senior living services, and healthcare real estate activities. This SEC filings page brings together those documents, along with AI-powered tools that help explain the information they contain.
Ensign’s current reports on Form 8-K discuss topics such as quarterly financial results, the use of non-GAAP financial measures, and changes in board composition and executive roles. In these filings, the company explains how it calculates measures like Adjusted Net Income, Adjusted Earnings per Share, EBITDA, Adjusted EBITDA, Adjusted EBITDAR, Adjusted EBT and Funds from Operations (FFO) for its Standard Bearer real estate segment. These definitions help investors understand how Ensign evaluates performance in its skilled services and real estate businesses.
Through this page, users can access Ensign’s annual reports on Form 10-K, quarterly reports on Form 10-Q and current reports on Form 8-K as they are made available on EDGAR. AI-generated summaries highlight key points from lengthy filings, such as segment descriptions, the role of Standard Bearer Healthcare REIT, Inc., and the company’s approach to non-GAAP metrics. The platform also surfaces relevant information from Forms 3, 4 and 5 related to equity ownership and transactions by directors and officers, giving additional context on insider activity.
By combining real-time SEC updates with AI explanations, this ENSG filings page is intended to make Ensign’s regulatory disclosures more accessible to investors who want to understand its skilled nursing, senior living and healthcare real estate operations in greater depth.
The Ensign Group, Inc. (ENSG) filed a Form S-8 with the SEC on June 26, 2025 to register 4,230,804 additional shares of common stock (par $0.001) for issuance under its Amended and Restated 2022 Omnibus Incentive Plan. These shares are in addition to the 3,462,897 shares previously registered on October 26, 2022 (File No. 333-268018), bringing the total registration for the plan to roughly 7.7 million shares. The filing relies on General Instruction E of Form S-8 and incorporates by reference ENSG’s 2024 Form 10-K, its Q1-25 Form 10-Q, and three 2025 Form 8-Ks. Standard Delaware law indemnification provisions, exhibits (plan document, legal opinion, Deloitte consent, etc.), and Form S-8 undertakings are included. No financial results or new strategic transactions are disclosed; the document is strictly an administrative registration to cover future equity-based compensation grants.
Ensign Group (NASDAQ: ENSG) filed a Form 4 disclosing that Vice President & Chief Legal Officer Beverly B. Wittekind executed an option exercise and same-day sale on 18 June 2025 under a Rule 10b5-1 plan adopted 12 Sep 2024.
The officer exercised 4,719 employee stock options at an exercise price of $45.34, acquiring 4,719 common shares. All newly issued shares were immediately sold at $155.00 per share, generating gross proceeds of approximately $0.73 million.
After the sale, Wittekind’s direct ownership returned to 38,679 shares, unchanged in absolute terms but representing a disposal of roughly 11 % of her previously reported stake. No derivative securities remain outstanding from the exercised grant, which originally vested in five equal installments between 2020 and 2024.